6-Month Buy/Sell Trend
Buys
Sells
▶
2026-04-01
1 other
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Ferrante Karen Jean | — | A | 686 | $0 | $0 | Apr 3 |
▶
2026-03-31
▼ 1 sell
· $242.6M
2 other
▶
2026-01-22
▼ 1 sell
· $127.4M
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Fairmount Funds Management LLC | — | ▼ Sell | 3,500,000 | $36 | $127.4M | Jan 22 |
▶
2026-01-01
1 other
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Ferrante Karen Jean | — | A | 643 | $0 | $0 | Jan 5 |
▶
2025-12-26
▼ 4 sells
· $12.2M
⚡ 4 insiders
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Robinson John Edward | Chief Scientific Officer | ▼ Sell | 90,000 | $39 | $3.5M | Dec 30 | |
| Sachs Jessica | Chief Medical Officer | ▼ Sell | 82,642 | $39 | $3.2M | Dec 30 | |
| Green John L. | Chief Financial Officer | ▼ Sell | 77,000 | $39 | $3.0M | Dec 30 | |
| Kearns Evan | Chief Legal Officer | ▼ Sell | 65,000 | $39 | $2.5M | Dec 30 |
▶
2025-12-17
24 other
⚡ 6 insiders
| Insider | Title | Type | Shares | Price | $ Value | 10b5-1 | Filed |
|---|---|---|---|---|---|---|---|
| Green John L. | Chief Financial Officer | A | 50,000 | $0 | $0 | Dec 19 | |
| Green John L. | Chief Financial Officer | A | 300,000 | $0 | $0 | Dec 19 | |
| Green John L. | Chief Financial Officer | F | 145,007 | $39 | $5.7M | Dec 19 | |
| Green John L. | Chief Financial Officer | A | 65,000 | $0 | $0 | Dec 19 | |
| Kearns Evan | Chief Legal Officer | A | 40,000 | $0 | $0 | Dec 19 | |
| Kearns Evan | Chief Legal Officer | A | 260,000 | $0 | $0 | Dec 19 | |
| Kearns Evan | Chief Legal Officer | F | 125,602 | $39 | $5.0M | Dec 19 | |
| Kearns Evan | Chief Legal Officer | A | 55,000 | $0 | $0 | Dec 19 | |
| Sachs Jessica | Chief Medical Officer | A | 50,000 | $0 | $0 | Dec 19 | |
| Sachs Jessica | Chief Medical Officer | A | 320,000 | $0 | $0 | Dec 19 | |
| Sachs Jessica | Chief Medical Officer | F | 154,716 | $39 | $6.1M | Dec 19 | |
| Sachs Jessica | Chief Medical Officer | A | 65,000 | $0 | $0 | Dec 19 | |
| Pinnow Cole | Chief Commercial Officer | A | 50,000 | $0 | $0 | Dec 19 | |
| Pinnow Cole | Chief Commercial Officer | A | 214,000 | $0 | $0 | Dec 19 | |
| Pinnow Cole | Chief Commercial Officer | F | 94,800 | $39 | $3.7M | Dec 19 | |
| Pinnow Cole | Chief Commercial Officer | A | 65,000 | $0 | $0 | Dec 19 | |
| Robbins Andrew R | President and CEO | A | 185,000 | $0 | $0 | Dec 19 | |
| Robbins Andrew R | President and CEO | A | 840,000 | $0 | $0 | Dec 19 | |
| Robbins Andrew R | President and CEO | F | 367,497 | $39 | $14.5M | Dec 19 | |
| Robbins Andrew R | President and CEO | A | 245,000 | $0 | $0 | Dec 19 | |
| Robinson John Edward | Chief Scientific Officer | A | 50,000 | $0 | $0 | Dec 19 | |
| Robinson John Edward | Chief Scientific Officer | A | 320,000 | $0 | $0 | Dec 19 | |
| Robinson John Edward | Chief Scientific Officer | F | 139,998 | $39 | $5.5M | Dec 19 | |
| Robinson John Edward | Chief Scientific Officer | A | 65,000 | $0 | $0 | Dec 19 |